United States Home Infusion Therapy Market Forecast 2025–2033: Trends, Segmentation, and Strategic Insights

United States Home Infusion Therapy Market to Double by 2033, Driven by Aging Population and Technological Advancements

The United States home infusion therapy market is projected to reach an estimated US$ 20.59 billion by 2033, growing from US$ 10.26 billion in 2024 at a CAGR of 8.05% between 2025 and 2033, according to a new report by Renub Research.

This rapid growth is fueled by the surging prevalence of chronic diseases, advancements in home healthcare technologies, and a paradigm shift toward patient-centric, cost-effective treatments delivered in the comfort of home.

💡 Market Overview

Home infusion therapy allows patients to receive intravenous (IV) or injectable treatments at home, reducing hospital stays and improving quality of life. Treatments include antibiotics, chemotherapy, hydration therapy, nutrition support, and more.

🔍 Key Growth Drivers

• Rising Chronic Diseases: Conditions like diabetes, cancer, and cardiovascular diseases are prompting long-term treatment at home.
• Technological Innovation: Portable infusion pumps and remote monitoring systems enhance patient safety and treatment precision.
• Aging Population: By 2060, 23% of Americans will be 65+, fueling demand for at-home care solutions.
• Personalized Care: Higher patient satisfaction and reduced infection risk are encouraging broader adoption.

🚧 Market Challenges

• High Equipment Costs: Advanced devices and specialty medications require significant investment.
• Workforce Shortages: The demand for trained nurses and pharmacists outpaces current availability.

New Publish Reports

• United States Bakeware Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033
• United States Bottled Water Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033
• United States Frozen Food Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033
• United States Olive Oil Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033

🔬 Segment Highlights

• Anti-Infective Therapy: Growing due to infections like sepsis requiring prolonged antibiotic care.
• Chemotherapy at Home: Enhanced by portable devices, offering patients privacy and emotional well-being.
• Infusion Pumps Market: Rising due to smart pumps with wireless monitoring—e.g., Infuzamed’s wearable pump launched in 2024.
• IV Sets Market: Essential for safe home-based medication delivery, especially for chronic and post-op patients.

🌎 Regional Insights

• California: Market expansion fueled by chronic disease prevalence and strong healthcare infrastructure.
• New York: Growth supported by efforts to decongest hospitals and enhance rural healthcare.
• Texas & Florida: Large aging populations and healthcare accessibility initiatives are driving adoption.

🏢 Key Players

• Baxter International Inc.
• Becton Dickinson and Company
• Eli Lilly & Company
• Fresenius SE & Co. KGaA
• ICU Medical Inc.
• Option Care Health Inc.
• Terumo Corporation

📈 Report Details

• Forecast Period: 2025–2033
• Segments: By Application (Anti-Infective, Chemotherapy, etc.), Product (Pumps, IV Sets, etc.), and 29 U.S. States
• Customization Available: Region-specific trends, competitive analysis, trade insights, and more

📞 Contact Us

To learn more or to request custom insights, contact Renub Research analysts today. Discover how your organization can leverage the latest market trends to stay ahead.

❓ Frequently Asked Questions (FAQs)

1. What is the projected size of the U.S. home infusion therapy market by 2033?

The market is forecasted to reach US$ 20.59 billion by 2033.

2. What is the expected CAGR for this market?

From 2025 to 2033, the market is expected to grow at a CAGR of 8.05%.

3. Which factors are driving market growth?

Key drivers include the rise in chronic diseases, aging population, technological advancements, and increasing demand for cost-effective and personalized home care.

4. How does home infusion therapy benefit patients?

Patients benefit from enhanced comfort, reduced hospital visits, lower infection risk, improved treatment adherence, and cost savings.

5. What are the major challenges in the market?

High costs of infusion devices and a shortage of skilled professionals are primary challenges.

6. Which application areas are covered in the market analysis?

Applications include:

• Anti-Infective
• Endocrinology
• Hydration Therapy
• Chemotherapy
• Enteral and Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

7. What role does technology play in market expansion?

Technological innovations like wearable infusion pumps and real-time monitoring systems are increasing treatment safety, flexibility, and efficiency at home.

8. Which states are analyzed in the report?

29 states including California, Texas, New York, Florida, Illinois, and others are covered, with regional insights on demand, infrastructure, and healthcare policies.

9. Why is the aging population important for this market?

Older adults are more likely to suffer from chronic conditions and prefer home-based treatment, making them a key consumer group.

10. Who are the leading companies in the U.S. home infusion therapy market?

Top players include Baxter, Fresenius, Option Care Health, and ICU Medical, among others.